Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate

Patients with advanced germ cell tumors can be cured with cisplatin-based chemotherapy, but the outcome remains unsatisfactory for patients with relapsed disease, including those patients with refractory disease after bone marrow transplantation. Targeted therapies have changed the standard of care...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasent Blesa, Joan Manel, Grande Pulido, Enrique, Laforga Canales, Juan, Alberola Candel, Vicente
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2009
Materias:
Published: December 2009
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914388/
https://www.ncbi.nlm.nih.gov/pubmed/20737043
http://dx.doi.org/10.1159/000260901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914388/
https://www.ncbi.nlm.nih.gov/pubmed/20737043
http://dx.doi.org/10.1159/000260901

Ejemplares similares